NASDAQ · Biotechnology

KOD (KOD) Stock

$41.58 -2.16% NASDAQ: KOD Healthcare

Valuation

MetricValue
Price$41.58
Market Cap$2.60B
P/E Ratio-8.11
P/B Ratio11.81
P/S Ratio0.00
EPS (TTM)$-4.32
52-Week High$47.84
52-Week Low$3.51
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-146.50%
ROA-65.34%
ROCE-148.10%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.50
Current Ratio4.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-267.0M$-341.0M$-277.0M$-187.0M$-234.0M
Net Profit$-267.0M$-334.0M$-260.0M$-176.0M$-230.0M
EPS$-5.16$-6.39$-4.97$-3.35$-4.32
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$904.0M$667.0M$479.0M$336.0M$352.0M
Total Liabilities$241.0M$230.0M$214.0M$185.0M$194.0M
Cash$732.0M$190.0M$286.0M$168.0M$210.0M
Borrowings$180.0M$188.0M$182.0M$70.0M$59.0M

Latest News

Kodiak CFO Sells $1 Million in Stock as Shares Surge 650%. What Investors Should Know Motley Fool · Jun 10, 2026 Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans Simply Wall St. · Jun 6, 2026 Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know Zacks · Jun 4, 2026 Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference PR Newswire · May 28, 2026 Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase Motley Fool · May 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-182.0M$-206.0M$-154.0M$-117.0M$-136.0M
Investing Cash Flow$-102.0M$-384.0M$208.0M$-1.0M$-1.0M
Financing Cash Flow$8.0M$0$0$0$0
Net Cash Flow$-213.0M$-541.0M$95.0M$-118.0M$42.0M
Free Cash Flow$-246.0M$-254.0M$-196.0M$-118.0M$-137.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-8.13%
Quick Ratio3.54
Interest Coverage—
Return 1Y651.25%
Return 3Y475.03%
Return 5Y-51.13%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANAB $53.61 -1.00% -127.70 $2.31B 0.00%
BBOT $8.09 -4.82% -3.62 $648.07M 0.00%
EYPT $12.41 +1.80% -4.34 $1.04B 0.00%
NRIX $24.11 -0.17% -6.41 $2.50B 0.00%
OCS $11.29 +2.08% -14.61 $645.16M 0.00%

About KOD

KOD stock trades at $41.58 with a market capitalization of $2.60B. The stock is valued at a price-to-earnings (P/E) ratio of -8.11, price-to-book of 11.81, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.51 and $47.84, and currently trades 13.1% below its 52-week high.

On profitability, KOD generates a return on equity (ROE) of -146.50%, return on capital employed of -148.10%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides